NASDAQ : MCTA
Charming Medical Limited — Key statistics
Healthcare · Medical Care Facilities · Hong Kong
Last price 29.11 USD (Nov 11, 2025, 4:00 PM EDT) · Market cap 504.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 504.26M |
| Enterprise Value | 502.48M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 15.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +5.29% |
| Shares Change (QoQ) | +10.59% |
| Owned by Insiders (%) | 68.19% |
| Owned by Institutions (%) | 0.34% |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 104.89 |
| Forward PS | n/a |
| PB Ratio | 97.33 |
| P/TBV Ratio | 97.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 104.51 |
| EV / EBITDA | 1,548.07 |
| EV / EBIT | 4,630.75 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.04 |
| Debt / FCF | n/a |
| Interest Coverage | 6.87 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -0.87% |
| Return on Assets (ROA) | 0.89% |
| Return on Invested Capital (ROIC) | 1.86% |
| Return on Capital Employed (ROCE) | 1.96% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $165,783 |
| Profits Per Employee | -$781 |
| Employee Count | 29 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 6.68 |
Taxes
| Measure | Value |
|---|
| Income Tax | 156,114 |
| Effective Tax Rate | 116.97% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 81.33 |
| Average Volume (20 Days) | 874,470 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 574,490 |
| Short Previous Month | 574,510 |
| Short % of Shares Out | 3.34% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.81M |
| Gross Profit | 4.63M |
| Operating Income | 108,509 |
| Pretax Income | 133,466 |
| Net Income | -22,648 |
| EBITDA | 324,583 |
| EBIT | 108,509 |
| Loss Per Share | -$0.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.68M |
| Total Debt | 908,016 |
| Net Cash | 6.77M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 5.18M |
| Book Value Per Share | 0.30 |
| Working Capital | 3.84M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.22M |
| Capital Expenditures | -339,560 |
| Depreciation & Amortization | 216,074 |
| Net Borrowing | -445,784 |
| Free Cash Flow | -1.56M |
| FCF Per Share | -$0.09 |
Margins
| Measure | Value |
|---|
| Gross Margin | 96.36% |
| Operating Margin | 2.26% |
| Pretax Margin | 2.78% |
| Profit Margin | -0.47% |
| EBITDA Margin | 6.75% |
| EBIT Margin | 2.26% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.29% |
| Shareholder Yield | -5.29% |
| Earnings Yield | -0.00% |
| FCF Yield | -0.31% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 40.59 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |